Mailroom Scanners
PRODUCTS
-
Ensure safe and effective development of highly potent therapies with our proven expertise, specialized facilities, and robust containment systems designed to support every drug development stage.
-
The IADA-2050PSM is an integrated MMIC active doubler fabricated with GaAs Schottky diodes that operates over a guaranteed 10 to 25 GHz input frequency range or a doubled output frequency range of 20to 50 GHz.
-
Reduce manual validation efforts, cut costs by up to 30%, get new products out the door faster, and enable seamless regulatory inspections.
-
The revolutionary ThermAer Process achieves the results you want without compromising quality or cost objectives.
-
Flanged pipe and fittings are key components in rigid piping systems, ideally suited for above-ground installations in water filtration plants, sewage disposal facilities, wastewater treatment plants, pumping stations, and industrial plants, per AWWA C115/A21.15 standards.
WHITE PAPERS AND CASE STUDIES
-
Navigating The European Market's Regulatory Complexities
Prepare your EU launch strategy with this comprehensive guide detailing what is needed to ensure compliance and efficiency in the EU market.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Next-Generation Fluorescence-Based Life Science Instrument
Next-gen fluorescence imaging prototype delivers compact, multi-color LED/laser illumination, high-precision optics, robust motion control, and validated imaging performance, ensuring superior sensitivity, stability, and repeatable results.
-
A Feeder-Free Platform For Generating Mature Natural Killer Cells
NK cells represent a promising avenue for immunotherapy. Examine the advantages of NK cells in cellular immunotherapy and the importance of developing efficient activation and expansion platforms.
-
Vial Fogging: Practical Considerations For Vial Selection
Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.
-
How Digitized Protocols Are Accelerating Clinical Research
Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.
-
Revolutionizing Pharmaceutical Quality Control
Learn about a South Korean pharmaceutical company's QC laboratory and how the operation of its chromatography systems has been transformed by implementing a real-time monitoring system.
-
Progressing A Cystic Fibrosis Treatment With A Strong Culture Match
Collaborate with an experienced CMO that combines transparency, expertise, and a shared commitment to help advance complex biologics from preclinical research to clinical success.
-
Disinfection For Purified Water Loop For Kamada Pharmaceuticals, Israel
An Atlantium HOD™ (Hydro-Optic Disinfection) UV system was installed at the outlet of a PW tank to serve as the primary disinfection barrier, with water circulating through the system at 6m³/hr before reaching the points of use.
-
Optimizing Upstream Process Development To Increase mAb Titers
Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.
-
2nd Generation ATAD Provides Superior Treatment
In a bold move to modernize its wastewater treatment, Bowling Green, Ohio, installed the state’s first second-generation Autothermal Thermophilic Aerobic Digestion (ATAD) system—ThermAer—in 2004. The upgrade expanded the plant’s capacity from 6 to 10 MGD and replaced an inefficient, odor-prone coarse-bubble aeration system.
-
Drinking Water Disinfection In A New Hampshire Town
The town of Hillsborough, NH chose Atlantium's HOD UV system to disinfect their drinking water due to its low disinfection by-products and reliable virus inactivation. Atlantium's UV technology is validated and offers stable and efficient water treatment solutions.
NEWS
-
Superior Energy Services Announces Entry Into Definitive Agreements To Acquire Abaco Energy Technologies, Expanding Global Capabilities And Downhole Tools Rental Portfolio1/21/2026
Superior Energy Services, Inc. (“Superior”) announces that it has entered into a definitive agreement to acquire Abaco Energy Technologies (“Abaco”), a leading global provider of proprietary power section technologies for downhole drilling, completion and remediation operations.
-
AbTherx And Dragonfly Therapeutics Expand Antibody Discovery Partnership9/23/2025
AbTherx, a biotechnology company pioneering technologies that accelerate antibody discovery, today announced an expansion of its ongoing partnership with Dragonfly Therapeutics (Dragonfly) following a successful multi-target pilot study comparing transgenic platforms.
-
Nikon Launches VOXLS 20 C 225 X-Ray And CT System4/30/2025
Nikon Corporation (Nikon) has launched the VOXLS 20 C 225, the latest addition to its VOXLS X-ray CT product lineup. This system is based on the proven principles of the company’s VOXLS 30 and 40 Series systems while offering maximum capability in a space-efficient footprint, providing unparalleled value per voxel in the market.
-
Artificio Processes Documents In 80+ Languages, Enabling Multinational Corporations To Automate Global Operations12/9/2025
Artificio Products Inc., a leader in AI-powered intelligent document processing and enterprise workflow automation, today announced that its platform now processes documents in more than 80 languages, positioning the company as a comprehensive solution for multinational corporations managing cross-border document operations.
-
ArriVent BioPharma Enters Exclusive License With Lepu Biopharma For MRG007, An Antibody Drug Conjugate For The Treatment Of Gastrointestinal Cancers1/21/2025
ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it has entered into an exclusive license agreement with Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) for MRG007, an antibody-drug conjugate (ADC) that can target several gastrointestinal (GI) cancers.